NPY decreased PD-1+ T cells and PD-1 expression/cell in T cells of both healthy individuals and patients with hepatocellular carcinoma; the peptide augmented T cell proliferation and the eradication of hepatocellular carcinoma cells [162]. This evidence concerns the gene NPY and hepatocellular carcinoma.